LCTX Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Lineage Cell Therapeutics Inc (LCTX.A) Moving Averages Convergence Divergence (MACD) indicator is -0.0305, suggesting LCTX.A is Neutral.

Lineage Cell Therapeutics Inc (LCTX.A) 20-Day simple moving average is 1.671, while Lineage Cell Therapeutics Inc (LCTX.A) share price is $1.57, making it Sell.

Lineage Cell Therapeutics Inc (LCTX.A) 60-Day simple moving average is 1.716, while Lineage Cell Therapeutics Inc (LCTX.A) share price is $1.57, making it Sell.

Technical Analysis for LCTX

Technical Sentiment Analysis for Lineage Cell Therapeutics Inc (LCTX) As of 2026-01-29, Lineage Cell Therapeutics Inc (LCTX) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 6 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for LCTX stands at 41.312, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0305, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 13.75 and the Commodity Channel Index (CCI) at -158.253 further confirm a -0.13 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, LCTX is trading above its 60-day moving average of $1.716 and above its 200-day long-term moving average of $1.256. Key price levels to watch include the immediate resistance at $1.733 and strong support at $1.528. A break above $1.733 could signal a bull continuation, while falling below $1.528 may test the next Fibonacci floor at $1.426.

Lineage Cell Therapeutics Inc (LCTX) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	1.322	1.426	1.528	1.632	1.733	1.837	1.939
Fibonacci	1.426	1.505	1.553	1.632	1.71	1.758	1.837

Lineage Cell Therapeutics Inc (LCTX) Technical Indicators

2026-01-29

Name	Value
RSI_14	41.312
STOCHk_14_3_3	13.75
STOCHd_14_3_3	10.946
CCI_20	-158.253
AO_5_34	-0.0746
MOM_10	-0.13
MACD_12_26_9	-0.0305

Lineage Cell Therapeutics Inc (LCTX) Relative Strength Index (RSI) is 41.312, creating a Neutral signal.

Lineage Cell Therapeutics Inc (LCTX) Stochastic Oscillator is 13.75, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Stochastic RSI is 10.946, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Commodity Channel Index (CCI) is -158.253, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Awesome Oscillator is -0.0746, creating a Sell signal.

Lineage Cell Therapeutics Inc (LCTX) Momentum is -0.13, creating a Sell signal.

Lineage Cell Therapeutics Inc (LCTX) MACD is -0.0305, creating a Sell signal.

Lineage Cell Therapeutics Inc (LCTX) Moving Average

2026-01-29

Period	Simple	Signal
MA_5	1.596	Sell
MA_10	1.629	Sell
MA_20	1.671	Sell
MA_60	1.716	Sell
MA_200	1.256	Buy
MA_250	1.116	Buy

Lineage Cell Therapeutics Inc (LCTX) 5-Day simple moving average is 1.596, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.57, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 10-Day simple moving average is 1.629, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.57, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 20-Day simple moving average is 1.671, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.57, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 60-Day simple moving average is 1.716, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.57, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 200-Day simple moving average is 1.256, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.57, making it a Buy.

Lineage Cell Therapeutics Inc (LCTX) 250-Day simple moving average is 1.116, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.57, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for LCTX?

The overall technical consensus for Lineage Cell Therapeutics Inc (LCTX) is currently neutral. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 3 sell signals.

What are the key support and resistance levels for Lineage Cell Therapeutics Inc (LCTX) today?

Based on pivot point calculations, Lineage Cell Therapeutics Inc (LCTX) has an immediate support level at 1.528 and a major resistance level at 1.733. Traders also monitor the pivot point at 1.632 to determine the intraday trend direction.

Is Lineage Cell Therapeutics Inc (LCTX) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Lineage Cell Therapeutics Inc (LCTX) is currently 41.312. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Lineage Cell Therapeutics Inc (LCTX)?

Lineage Cell Therapeutics Inc (LCTX) Moving Averages Convergence Divergence (MACD) indicator is -0.0305, suggesting LCTX is neutral. This indicator helps identify potential trend reversals or momentum shifts for Lineage Cell Therapeutics Inc.

How is Lineage Cell Therapeutics Inc (LCTX) performing relative to its 200-day moving average?

Lineage Cell Therapeutics Inc (LCTX)is currently trading at $1.57, which is above its 200-day simple moving average of 1.256. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.